Barostim System
AssetAlso BATwire Implant Kit, Barostim NEO, Barostim NEO2
Implantable device that delivers baroreflex activation therapy to modulate autonomic balance in heart failure
- Stage
- Human trials
- Modality
- Device
- Target
- Not known
- 1
- Indication
- 1
- Trial
- 1
- Developer
Indications
1Heart failure
Human trials, Terminated, NCT04600791, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Owner and partners1
- Trials1
- Competitors9
Every asset’s record: target, stage, trials and the evidence behind it.